SERA PROGNOSTICS, INC. (SERA)

↓ Download CSV

CIK 0001534969 · Nasdaq · Services-Medical Laboratories

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, SERA PROGNOSTICS, INC. reported revenue of $81.0K, up 5.2% from the prior year. The company ran a net loss, with a net margin of -39417.3%. It held $101.93M in total assets against $26.52M in total liabilities.

Key ratios (FY2025)

-45066.7%
Operating margin
-39417.3%
Net margin
-42.3%
Return on equity
+5.2%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019
Revenue$81.0K$77.0K$306.0K$268.0K$82.0K$25.0K
Cost of Revenue$164.0K$82.0K$210.0K
Operating Income-$36.50M-$36.63M-$39.82M-$45.65M-$35.40M-$17.97M
Net Income-$31.93M-$32.90M-$36.24M-$44.19M-$35.01M-$19.85M
EPS (Diluted)$-0.67$-0.99$-1.16$-1.43$-2.33$-12.76
Total Assets$101.93M$72.58M$95.44M$116.33M$147.03M$14.80M
Total Liabilities$26.52M$24.77M$25.28M$17.39M$8.46M$12.33M
Shareholders' Equity$75.41M$47.80M$70.16M$98.94M$138.56M-$125.57M-$106.62M
Cash & Equivalents$3.94M$4.04M$3.88M$29.88M$58.93M$13.53M
Operating Cash Flow-$25.62M-$14.19M-$27.19M-$34.61M-$31.64M-$16.87M
Capital Expenditures$726.0K$56.0K$128.0K$791.0K$1.30M$149.0K
Shares Outstanding47.66M33.16M31.20M30.94M15.00M1.56M